PR

Home
PR | Press Release

Press Release

2020 / 05 / 13

Pharmicell, a continuation of surplus - sales of 9.5 billion won • 900 million won net income
2020 / 04 / 29

Pharmicell Nucleoside, Last year's sales surpassed by continuous orders
2020 / 04 / 27

Recovery of two out of three severe corona19 patients with phamicell stem cell therapy
2020 / 04 / 24

Pharmicell, sales increase due to full-scale commercial supply of mPEGs
2020 / 03 / 31

Pharmicell, growth of raw material medicine business
2020 / 03 / 30

Pharmicell, stem cells medicine is approved to use Corona 19
2020 / 03 / 06

Pharmicell, continuous supply of raw material for diagnostic kits
2020 / 02 / 19

Phamicell, the upswing of nucleosides supplement
2020 / 01 / 28

Pharmicell's highest sales, operating profit, and net income last year
2020 / 01 / 10

Pharmicell’s Stem Cell Cosmetics entered into SM Duty-Free Store
2020 / 01 / 10

Pharmicell to commercially delivered MPEG to UCB, a global pharmaceutical company
2019 / 12 / 02

Pharmicell acquires patent for 'next-generation dendritic cell'
2019 / 08 / 19

Pharmicell applied for clinical phase 1, treatment for ovarian cancer therapy following prostate can
2019 / 08 / 05

Pharmicell anti-cancer immune cell therapy 'Cellgram-DC', commercialization started
2019 / 07 / 05

Pharmicell succeeds in recertifying ‘Innovative Pharmaceutical Company’